Target intelligence / Profile preview

Homeobox protein SIX5 (SIX5)

Target
SIX5
Molecular classification
Transcription factor, Homeobox protein, DNA-binding protein
01

Overview

Homeobox protein SIX5 (SIX5) is a member of the sine oculis (SIX) family of transcription factors, sharing a conserved N-terminal SIX domain (protein-protein interactions) and a homeodomain (DNA binding). It is essential in vertebrate development, notably for the retina, spermatogenesis, and the cardiac conduction system, but not directly required for skeletal muscle phenotype in myotonic dystrophy type 1. Reduced SIX5 function, often stemming from DMPK locus trinucleotide expansion in myotonic dystrophy, contributes to multisystem manifestations such as cataracts and conduction defects. The SIX5 gene is subject to epigenetic regulation, and altered expression and methylation status play pathogenic roles in DM1. No approved drugs directly target SIX5, and its principal functions are as a sequence-specific DNA binding protein modulating transcription during development and tissue homeostasis.

Other names
DMAHPDM locus-associated homeodomain proteinSine oculis homeobox homolog 5BOR2Dystrophia myotonica-associated homeodomain proteinHomeobox protein SIX5
02

Mechanism of action

Not applicable; no specific drugs or inhibitors targeting SIX5 are reported. Mechanism relates to transcriptional gene regulation via DNA binding and protein-protein interactions

03

Biological functions

Regulation of gene expression during developmentDetermination and maintenance of retina formationSpermatogonia viability; spermatozoa differentiationCardiac conduction system function
04

Disease associations

Myotonic dystrophy type 1 (DM1)CataractsMale infertility (impaired spermatogenesis)Cardiac conduction defects
05

Safety considerations

Targeting transcription factors generally carries risk of off-target effects impacting multiple developmental and tissue-specific processesLoss of SIX5 function leads to cataracts, male infertility, and cardiac conduction defects in mouse modelsDNA methylation changes relevant to SIX5 could potentially have broad physiological impacts
06

Biomarkers

SIX5 expression may be altered in DM1 due to epigenetic effects (DNA/histone methylation), and alteration can serve as a biomarker for DM1 status or activityTrinucleotide expansion near the SIX5 gene is a biomarker for myotonic dystrophy type 1

Beyond the preview

Go deeper on Homeobox protein SIX5 (SIX5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homeobox protein SIX5 (SIX5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call